Salarius Pharmaceuticals, Inc. (Nasdaq:SLRX)
Health Care/Life Sciences • Pharmaceuticals
CIK 1615219
Company
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. The company was founded in February 2014 and is headquartered in Houston, TX.
Address
2450 Holcombe Boulevard
Suite X
Houston, Texas 77021
2450 Holcombe Boulevard
Suite X
Houston, Texas 77021
Employees
2
2
Stock Info
Key Executives
Board Of Directors
Chairman William K. McVicar |
President, Chief Executive Officer & Director David J. Arthur |
Independent Director Bruce J. McCreedy |
Independent Director Arnold C. Hanish |
Lead Independent Director Paul Lammers |
Independent Director Teresa R. Burleson |
Independent Director Jonathan I. Lieber |
SEC filings
Date | Form | Event |
---|---|---|
16 Dec, 2024 | S-1 | |
13 Dec, 2024 | 8-K | |
14 Nov, 2024 | SC 13G/A | |
14 Nov, 2024 | 10-Q | |
1 Nov, 2024 | DEF 14A | |
1 Nov, 2024 | DEFA14A | |
27 Sep, 2024 | 8-K | |
15 Aug, 2024 | 8-K | |
14 Aug, 2024 | 8-K | |
9 Aug, 2024 | 10-Q | |
25 Jul, 2024 | 424B5 | |
25 Jul, 2024 | 8-K | |
23 Jul, 2024 | 8-K | |
22 Jul, 2024 | 424B5 | |
19 Jul, 2024 | 8-K | |
11 Jul, 2024 | 8-K | |
17 Jun, 2024 | 8-K | |
17 Jun, 2024 | 424B5 | |
14 Jun, 2024 | 8-K | |
13 May, 2024 | 10-Q | |
22 Apr, 2024 | 10-K/A | |
12 Apr, 2024 | 4 | |
26 Mar, 2024 | DEF 14A | |
26 Mar, 2024 | DEFA14A | |
22 Mar, 2024 | 10-K | |
20 Mar, 2024 | DFAN14A | |
15 Mar, 2024 | PRE 14A | |
6 Mar, 2024 | 8-K | |
23 Feb, 2024 | 8-K | CEO Change |
22 Feb, 2024 | 4 | |
22 Feb, 2024 | 4 | |
22 Feb, 2024 | 4 | |
22 Feb, 2024 | 4 | |
22 Feb, 2024 | 4 | |
22 Feb, 2024 | 4 | |
22 Feb, 2024 | 4 | |
14 Feb, 2024 | SC 13G | |
9 Nov, 2023 | 10-Q | |
27 Oct, 2023 | SC 13D | |
6 Sep, 2023 | 8-K | |
10 Aug, 2023 | 10-Q | |
10 Aug, 2023 | 8-K | |
12 Jul, 2023 | 8-K | |
15 Jun, 2023 | 8-K | |
7 Jun, 2023 | 424B3 | |
6 Jun, 2023 | EFFECT | |
2 Jun, 2023 | CORRESP | |
1 Jun, 2023 | S-3/A | |
1 Jun, 2023 | UPLOAD | |
26 May, 2023 | S-3 | |
25 May, 2023 | D | |
16 May, 2023 | 8-K | |
11 May, 2023 | 10-Q | |
1 May, 2023 | DEF 14A | |
1 May, 2023 | DEFA14A | |
27 Mar, 2023 | 10-K | |
13 Mar, 2023 | 8-K | |
15 Feb, 2023 | 4 | |
15 Feb, 2023 | S-8 | |
15 Feb, 2023 | 4 | |
13 Feb, 2023 | SC 13G/A | |
10 Jan, 2023 | 8-K | |
5 Jan, 2023 | 4 | |
5 Jan, 2023 | 4 | |
5 Jan, 2023 | 4 | |
5 Jan, 2023 | 4 | |
5 Jan, 2023 | 4 | |
5 Jan, 2023 | 4 | |
5 Jan, 2023 | 4 | |
5 Jan, 2023 | 4 | |
12 Dec, 2022 | 4/A | |
12 Dec, 2022 | 4/A | |
1 Dec, 2022 | 8-K | |
10 Nov, 2022 | 8-K | |
10 Nov, 2022 | 10-Q | |
8 Nov, 2022 | 4/A | |
8 Nov, 2022 | 4/A | |
7 Nov, 2022 | 4 | |
7 Nov, 2022 | 4 | |
3 Nov, 2022 | 8-K | |
27 Oct, 2022 | 8-K | |
18 Oct, 2022 | 8-K | |
14 Oct, 2022 | 8-K | |
16 Aug, 2022 | EFFECT | |
15 Aug, 2022 | 8-K | |
12 Aug, 2022 | CORRESP | |
10 Aug, 2022 | UPLOAD | |
5 Aug, 2022 | 10-Q | |
5 Aug, 2022 | S-3 | |
3 Aug, 2022 | 8-K | |
23 Jun, 2022 | EFFECT | |
21 Jun, 2022 | UPLOAD | |
21 Jun, 2022 | CORRESP | |
17 Jun, 2022 | 8-K | |
10 Jun, 2022 | S-3 | |
8 Jun, 2022 | 4 | |
8 Jun, 2022 | 4 | |
7 Jun, 2022 | 4 | |
6 Jun, 2022 | 4/A | |
6 Jun, 2022 | 4/A | |
6 Jun, 2022 | 4/A | |
6 Jun, 2022 | 4 | |
31 May, 2022 | 4 | |
31 May, 2022 | 4 | |
12 May, 2022 | 10-Q | |
12 May, 2022 | 8-K | |
12 May, 2022 | DEFA14A | |
9 May, 2022 | UPLOAD | |
6 May, 2022 | CORRESP | |
5 May, 2022 | 4 | |
29 Apr, 2022 | SC 13G | |
28 Apr, 2022 | DEF 14A | |
28 Apr, 2022 | DEFA14A | |
27 Apr, 2022 | SC 13G | |
26 Apr, 2022 | 424B5 | |
26 Apr, 2022 | 8-K | |
22 Apr, 2022 | 8-K | |
22 Apr, 2022 | UPLOAD | |
15 Apr, 2022 | PRE 14A | |
1 Apr, 2022 | 8-K | |
25 Mar, 2022 | 10-K | |
10 Mar, 2022 | 8-K | |
9 Mar, 2022 | 4 | |
9 Mar, 2022 | 4 | |
22 Feb, 2022 | S-8 | |
10 Feb, 2022 | SC 13G/A | |
21 Jan, 2022 | 4 | |
21 Jan, 2022 | 4 | |
21 Jan, 2022 | 4 | |
21 Jan, 2022 | 4 | |
21 Jan, 2022 | 4 | |
21 Jan, 2022 | 4 | |
21 Jan, 2022 | 4 | |
21 Jan, 2022 | 4 | |
13 Jan, 2022 | 8-K | |
19 Nov, 2021 | 8-K | |
5 Nov, 2021 | 4 | |
5 Nov, 2021 | 4 | |
4 Nov, 2021 | 10-Q | |
16 Sep, 2021 | 8-K | |
20 Aug, 2021 | 8-K | |
17 Aug, 2021 | 4 | |
11 Aug, 2021 | 4 | |
5 Aug, 2021 | 10-Q | |
5 Aug, 2021 | 8-K | |
2 Jul, 2021 | 424B5 | |
2 Jul, 2021 | 8-K | |
1 Jul, 2021 | 8-K | |
1 Jul, 2021 | 424B5 | |
16 Jun, 2021 | 8-K | |
20 May, 2021 | 8-K | |
12 May, 2021 | 8-K | |
12 May, 2021 | 10-Q | |
5 May, 2021 | 4 | |
5 May, 2021 | 4 | |
27 Apr, 2021 | DEFA14A | |
27 Apr, 2021 | DEF 14A | |
18 Mar, 2021 | 10-K | |
8 Mar, 2021 | 8-K | |
5 Mar, 2021 | 424B5 | |
3 Mar, 2021 | 424B5 | |
3 Mar, 2021 | 8-K | |
17 Feb, 2021 | 8-K | |
16 Feb, 2021 | SC 13G/A | |
16 Feb, 2021 | SC 13G | |
12 Feb, 2021 | SC 13G/A | |
5 Feb, 2021 | 8-K | |
5 Feb, 2021 | 424B5 | |
1 Feb, 2021 | EFFECT | |
28 Jan, 2021 | SC 13G/A | |
28 Jan, 2021 | CORRESP | |
21 Jan, 2021 | 8-K | |
20 Jan, 2021 | UPLOAD | |
15 Jan, 2021 | S-3 |
Last update:2025-03-06 12:05:28.311986
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.